London
· Delayed Price · Currency is GBP · Price in SEK BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of GBP 893.91 million. The enterprise value is 812.78 million.
| Market Cap | 893.91M |
| Enterprise Value | 812.78M |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | May 8, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 81.03M |
Valuation Ratios
The trailing PE ratio is 36.08.
| PE Ratio | 36.08 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 8.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.08, with an EV/FCF ratio of 30.25.
| EV / Earnings | 32.80 |
| EV / Sales | 8.24 |
| EV / EBITDA | 23.08 |
| EV / EBIT | 24.35 |
| EV / FCF | 30.25 |
Financial Position
The company has a current ratio of 7.78
| Current Ratio | 7.78 |
| Quick Ratio | 5.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 27.65 |
Financial Efficiency
Return on equity (ROE) is 18.69% and return on invested capital (ROIC) is 15.90%.
| Return on Equity (ROE) | 18.69% |
| Return on Assets (ROA) | 13.62% |
| Return on Invested Capital (ROIC) | 15.90% |
| Return on Capital Employed (ROCE) | 26.78% |
| Revenue Per Employee | 449,219 |
| Profits Per Employee | 111,610 |
| Employee Count | 210 |
| Asset Turnover | 0.64 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.63% in the last 52 weeks. The beta is 0.59, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +8.63% |
| 50-Day Moving Average | 110.53 |
| 200-Day Moving Average | 116.82 |
| Relative Strength Index (RSI) | 72.10 |
| Average Volume (20 Days) | 2,196 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of GBP 99.73 million and earned 24.78 million in profits. Earnings per share was 0.25.
| Revenue | 99.73M |
| Gross Profit | 73.39M |
| Operating Income | 33.73M |
| Pretax Income | 31.74M |
| Net Income | 24.78M |
| EBITDA | 34.80M |
| EBIT | 33.73M |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
| Cash & Cash Equivalents | 81.99M |
| Total Debt | n/a |
| Net Cash | 81.99M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 119.16M |
| Book Value Per Share | 1.18 |
| Working Capital | 95.94M |
Cash Flow
In the last 12 months, operating cash flow was 28.90 million and capital expenditures -2.04 million, giving a free cash flow of 26.86 million.
| Operating Cash Flow | 28.90M |
| Capital Expenditures | -2.04M |
| Free Cash Flow | 26.86M |
| FCF Per Share | n/a |
Margins
Gross margin is 73.59%, with operating and profit margins of 33.82% and 24.85%.
| Gross Margin | 73.59% |
| Operating Margin | 33.82% |
| Pretax Margin | 31.83% |
| Profit Margin | 24.85% |
| EBITDA Margin | 34.90% |
| EBIT Margin | 33.82% |
| FCF Margin | 26.94% |
Dividends & Yields
BioGaia AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 123.93% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 163.40% |
| Buyback Yield | -0.07% |
| Shareholder Yield | -0.07% |
| Earnings Yield | 2.77% |
| FCF Yield | 3.01% |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |